Long term assessment of neurological effects after red tide exposure

赤潮暴露后神经系统影响的长期评估

基本信息

  • 批准号:
    10155490
  • 负责人:
  • 金额:
    $ 19.01万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-05-01 至 2023-04-30
  • 项目状态:
    已结题

项目摘要

Abstract: Karenia brevis (K. brevis), the microalgae responsible for Red Tide harmful algal blooms, regularly releases a suite of potent neurotoxic brevetoxins in southwest Florida and is intermittently responsible for massive marine life morbidity and mortality. While these blooms have been documented in the Gulf of Mexico since the 16th century, evidence suggests that their frequency and intensity have been increasing in recent decades, most likely driven by human development in Florida and higher Gulf water temperatures. Although the acute negative consequences of Red Tide exposure on pulmonary health in humans are relatively well-documented, recent studies of ER admissions during Red Tide blooms also demonstrate increased diagnoses of neurological conditions. The impact on the central nervous system of repeat exposure of brevetoxin in humans is not known, but frequent exposure to the closely-related ciguatoxin can result in chronic neurological illness including conditions similar to chronic fatigue syndrome. Furthermore, other chronically exposed mammals, like manatees and dolphins, display a wide variety of neurological signs most likely due to the known mechanism of action of brevetoxins on voltage-gated ion channels in the peripheral and central nervous systems. One of the longest Red Tide blooms on record, November 2017 to February 2019, exposed southwest Florida residents to prolonged and intense aerosolized brevetoxin levels. We have begun enrolling volunteer residents from the two-county region of Manatee and Sarasota (collectively “Manasota”) who were differentially exposed during this bloom by virtue of their home or work locations. These subjects have provided demographic, health history, and zone/activity information as well as biological samples. These subjects will be part of the cohort that we would like to follow over 18 months during periods of absence or presence of subsequent blooms. The cohort recruitment will be completed with volunteers who live in coastal regions as well as those who live further inland and who will have experienced much lower, or no, brevetoxin aerosol exposure. We will correlate their exposure to aerosolized brevetoxins with neurological diagnoses. Furthermore, we will examine biomarkers of brevetoxin exposure in relation to the same neurological sequelae. The purpose of this study is to determine how exposure relates to neurological diagnoses and to begin to characterize differences between those that develop neurological diagnoses and those that do not. For instance, exposure dose, duration, or markers of immune response may predict neurological outcomes. This work will be the first to provide longitudinal data on the neurological consequences of repeat brevetoxin exposure, generate a cohort for the examination of long-term outcomes and will establish a biorepository for studies of brevetoxin exposure and human health.
摘要: Karenia brevis(K. brevis),负责赤潮有害藻华的微藻,定期释放一种 佛罗里达西南部一组强效神经毒性短尾藻毒素,间歇性地导致大量海洋生物 终身发病率和死亡率。虽然自16日以来,墨西哥湾就有记录显示这些水华 世纪以来,有证据表明,近几十年来,这种现象的频率和强度一直在增加, 可能是由佛罗里达的人类发展和较高的海湾水温驱动的。虽然急性 赤潮暴露对人类肺部健康的负面影响是相对有据可查的, 最近对赤潮期间急诊室入院的研究也表明, 神经系统疾病重复暴露于短尾蛇毒素对人体中枢神经系统的影响 目前尚不清楚,但经常接触密切相关的雪卡毒素可导致慢性神经系统疾病 包括类似于慢性疲劳综合症的病症。此外,其他长期接触的哺乳动物,如 海牛和海豚,显示出各种各样的神经系统症状,最有可能是由于已知的机制, 在外周和中枢神经系统的电压门控离子通道的短毒素的行动。之一 有记录以来最长的赤潮,2017年11月至2019年2月,暴露在佛罗里达西南部 居民长期和强烈的烟雾状短尾丝虫毒素水平。 我们已经开始招募来自Manatee和Sarasota两个县地区的志愿者居民(统称为 “Manasota”),由于他们的家庭或工作地点,他们在这次水华期间受到不同程度的暴露。这些 受试者提供了人口统计学、健康史和区域/活动信息以及生物学信息, 样品这些受试者将成为我们希望在18个月内随访的队列的一部分, 没有或存在随后的开花。队列招募将在以下志愿者中完成: 在沿海地区,以及那些住在内陆的人,他们的生活水平要低得多,或者没有, 短尾丝虫毒素气溶胶暴露我们将把他们接触雾化短杆菌毒素与神经系统联系起来 诊断。此外,我们将检查与相同的短尾孢毒素暴露相关的生物标志物, 神经系统后遗症本研究的目的是确定暴露如何与神经系统 诊断,并开始表征那些发展神经学诊断和 那些没有。例如,暴露剂量、持续时间或免疫反应的标志物可以预测 神经系统结果。这项工作将是第一个提供纵向数据的神经 重复暴露于短尾孢毒素的后果,产生一个队列,用于检查长期结果 并将建立一个生物储藏库,用于研究短尾丝虫毒素接触和人类健康。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Laila Abdullah其他文献

Laila Abdullah的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Laila Abdullah', 18)}}的其他基金

The role of adaptive immunity in organophosphate induced CNS injury
适应性免疫在有机磷诱导的中枢神经系统损伤中的作用
  • 批准号:
    10629511
  • 财政年份:
    2023
  • 资助金额:
    $ 19.01万
  • 项目类别:
Cerebrovascular contributions to APOE4-mediated brain bioenergetic deficits in Alzheimer's disease
脑血管对 APOE4 介导的阿尔茨海默病脑生物能缺陷的影响
  • 批准号:
    10739352
  • 财政年份:
    2023
  • 资助金额:
    $ 19.01万
  • 项目类别:
The effects of APOE4 on carnitine/acylcarnitine mediated bioenergetic deficits in Alzheimer's disease
APOE4 对肉碱/酰基肉碱介导的阿尔茨海默病生物能缺陷的影响
  • 批准号:
    10370296
  • 财政年份:
    2021
  • 资助金额:
    $ 19.01万
  • 项目类别:
Influence of APOE genotypes on blood brain barrier transport of DHA by mfsd2a in Alzheimer's Disease
APOE基因型对阿尔茨海默病中mfsd2a血脑屏障转运DHA的影响
  • 批准号:
    10292958
  • 财政年份:
    2019
  • 资助金额:
    $ 19.01万
  • 项目类别:
Identifying APOE related lipid biomarkers for diagnosing chronic neurocognitive deficits in TBI patients
鉴定用于诊断 TBI 患者慢性神经认知缺陷的 APOE 相关脂质生物标志物
  • 批准号:
    10454875
  • 财政年份:
    2019
  • 资助金额:
    $ 19.01万
  • 项目类别:
Influence of APOE genotypes on blood brain barrier transport of DHA by mfsd2a in Alzheimer's Disease
APOE基因型对阿尔茨海默病中mfsd2a血脑屏障转运DHA的影响
  • 批准号:
    9663028
  • 财政年份:
    2019
  • 资助金额:
    $ 19.01万
  • 项目类别:
Influence of APOE genotypes on blood brain barrier transport of DHA by mfsd2a in Alzheimer's Disease
APOE基因型对阿尔茨海默病中mfsd2a血脑屏障转运DHA的影响
  • 批准号:
    10515657
  • 财政年份:
    2019
  • 资助金额:
    $ 19.01万
  • 项目类别:
Identifying APOE related lipid biomarkers for diagnosing chronic neurocognitive deficits in TBI patients
鉴定用于诊断 TBI 患者慢性神经认知缺陷的 APOE 相关脂质生物标志物
  • 批准号:
    9910069
  • 财政年份:
    2019
  • 资助金额:
    $ 19.01万
  • 项目类别:
Identifying APOE related lipid biomarkers for diagnosing chronic neurocognitive deficits in TBI patients
鉴定用于诊断 TBI 患者慢性神经认知缺陷的 APOE 相关脂质生物标志物
  • 批准号:
    10614552
  • 财政年份:
    2019
  • 资助金额:
    $ 19.01万
  • 项目类别:
Influence of APOE genotypes on blood brain barrier transport of DHA by mfsd2a in Alzheimer's Disease
APOE基因型对阿尔茨海默病中mfsd2a血脑屏障转运DHA的影响
  • 批准号:
    10043826
  • 财政年份:
    2019
  • 资助金额:
    $ 19.01万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.01万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 19.01万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.01万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.01万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.01万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.01万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.01万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 19.01万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 19.01万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 19.01万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了